NORPREG-SR 75 — Swastika Ventures Pharmaceuticals LLP

About NORPREG-SR 75

NORPREG-SR® 75 combines Pregabalin Sustained Release with Nortriptyline Hydrochloride, providing a combination approach to the management of neuropathic pain. The sustained-release formulation is designed to provide prolonged drug release as part of an appropriate therapeutic regimen prescribed by a physician.

Key Benefits

Combination approach for neuropathic pain management
Sustained-release Pregabalin formulation
May help address neuropathic pain symptoms
Designed for physician-guided therapy

⚠ Schedule H1 Prescription Drug — Caution: It is dangerous to take this preparation except in accordance with the prescription of a Registered Medical Practitioner. May cause dizziness or drowsiness. Patients should follow their physician's advice regarding driving and operating machinery.

Composition — per film-coated tablet

Ingredient	Strength
Pregabalin Sustained Release	75 mg
Nortriptyline Hydrochloride	10 mg

Indication

For the management of neuropathic pain, as prescribed by a qualified healthcare professional.

CategoryPrescription Medicine – Schedule H1

Pack Size15 Tablets

ManufacturerPartner Facility